Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2013)
Acadia Pharmaceuticals (ACAD) posted quarterly Interest & Investment Income of $41000.0 for Q1 2013, up 215.38% year-over-year from $13000.0 in Q1 2012, and up 355.56% quarter-over-quarter from $9000.0 in Q4 2012.
Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2013) Analysis & Trends
Acadia Pharmaceuticals' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $41000.0 for Q1 2013.
- In Q1 2013, Interest & Investment Income rose 215.38% year-over-year to $41000.0; the TTM figure through Mar 2013 stood at $65000.0 (down 9.72% YoY), while the FY2012 annual figure was $37000.0, down 57.47% from the prior year.
- Interest & Investment Income for Q1 2013 stood at $41000.0, up from $9000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $41000.0 in Q1 2013, with the low at $5000.0 in Q3 2012.
- The 4-year median for Interest & Investment Income is $13500.0 (2011), against an average of $16666.7.
- The sharpest annual moves came in 2011 and 2012: Interest & Investment Income soared 250.0% in 2011, then plunged 70.59% in 2012.
- Acadia Pharmaceuticals' Interest & Investment Income stood at $12000.0 in 2010, then rose by 16.67% to $14000.0 in 2011, then tumbled by 35.71% to $9000.0 in 2012, then jumped by 355.56% to $41000.0 in 2013.
- Business Quant data shows ACAD's Interest & Investment Income at $41000.0 in Q1 2013, $9000.0 in Q4 2012, and $5000.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 41,000.00 |
| Dec 31, 2012 | 9,000.00 |
| Sep 30, 2012 | 5,000.00 |
| Jun 30, 2012 | 10,000.00 |
| Mar 31, 2012 | 13,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Sep 30, 2011 | 17,000.00 |
| Jun 30, 2011 | 28,000.00 |
| Mar 31, 2011 | 28,000.00 |
| Dec 31, 2010 | 12,000.00 |
| Sep 30, 2010 | 15,000.00 |
| Jun 30, 2010 | 8,000.00 |